NO, a potent
vasodilator, has been implicated in the pathogenesis of
glucocorticoid hypertension.
NO synthase requires the cofactor
tetrahydrobiopterin for the production of NO.
Guanosine-triphosphate (
GTP) cyclohydrolase 1 is the rate-limiting
enzyme for the production of
tetrahydrobiopterin, and in the presence of low levels of
tetrahydrobiopterin, NO production is decreased. We have previously shown that
tetrahydrobiopterin-dependent vasodilation is impaired in rats with
glucocorticoid hypertension. However, the role
GTP cyclohydrolase 1 plays in the pathogenesis of
glucocorticoid hypertension has not been investigated. Therefore, we tested the hypothesis that downregulation of
GTP cyclohydrolase 1 contributes to the development and maintenance of
glucocorticoid hypertension in rats. Rats were implanted with
dexamethasone (0.79 mg x kg(-1) x d(-1)) or
sham-operated, and systolic blood pressures were measured at baseline and after 12 hours, 4 days, or 15 days. Blood pressure increased significantly after
dexamethasone treatment. Isometric force generation was measured in endothelium-intact aortic ring segments. Aortas from
dexamethasone-treated rats exhibited a significant time-dependent decrease in maximal relaxation to
acetylcholine compared with control rats. Incubation with
sepiapterin (10(-4) mol/L, 1 hour), which produces
tetrahydrobiopterin via a salvage pathway, restored vasodilation to
acetylcholine in aortas from 4- and 15-day
dexamethasone-treated rats.
GTP cyclohydrolase 1
mRNA expression levels also significantly decreased in a time-dependent manner. These results support the hypothesis that downregulation of
GTP cyclohydrolase 1 contributes to increased blood pressure in
glucocorticoid hypertensive rats.